Oncology Today with Dr Neil Love

Medical

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

Episodes

Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 2

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1

Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus

Endometrial Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Non-Small Cell Lung Cancer — Targeting KRAS G12C

Prostate Cancer — The Optimal Use of Hormonal Therapy

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists

Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program

Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal

For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress

Metastatic Triple-Negative Breast Cancer — Patterns of Care

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances

For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2026 Annual ONS Congress

HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway

AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium